Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Semaglutide is FDA-approved under different brand names: Ozempic and Rybelsus for type 2 diabetes
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer On March 20, 2026, the core compound patent for semaglutide held by the Danish pharmaceutical company Novo Nordisk will officially expire in China
Falling short of this target accelerates muscle loss and compounds fatigue through multiple pathways
Billing The center accepts most major insurance plans
Its dual-receptor action may make it a better fit for patients who need broader support with insulin response, cravings, and fat metabolism
.png)
US$ 29.65
US$ 26.80
US$ 29.16
US$ 28.96
US$ 24.58
